Schizophrenia and cognitive functioning: 2. Meaning, implications and treatment of cognitive deficits;Schizofrenia e funzioni cognitive: Una revisione critica della letteratura 2. Significato, implicazioni e trattamento dei deficit cognitivi

Rivista di Psichiatria

Volumn 37, Issue 2, 2002, Pages 53-60

  Gold, James ^a   De Girolamo, Giovanni ^a   Brambilla, Luisa ^a   Cappa, Stefano ^a   Mazzi, Fausto ^a   O'Donnell, Kathy ^a   Scala, Valnea ^a   Pioli, Rosaria ^a  

^a MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

Author keywords

Cognitive functioning; Schizophrenia; Treatment

Indexed keywords

NEUROLEPTIC AGENT;

COGNITION; COGNITIVE DEFECT; DISEASE ASSOCIATION; HUMAN; NEUROPSYCHOLOGICAL TEST; REVIEW; SCHIZOPHRENIA; SOCIAL PSYCHOLOGY;

EID: 0036113160     PISSN: 00356484     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Schizophrenic syndromes and frontal lobe performance
2. Neuropsychological deficit associated with schizophrenic syndromes
3. Cognitive impairment in schizophrenia
4. What are the functional consequences of neurocognitive deficit in schizofrenia?
5. Neurocognitive deficit in schizophrenia: A quantitative review of the evidence
6. Neurocognitive deficits and functional outcome in schizophrenia: Are we measuring the "right stuff"?
7. Neuropsychological and psychophysiological correlates of psychosocial functioning in schizophrenia
8. Symptoms, cognitive functioning, and adaptive skills in geriatric patients with lifelong schizophrenia: A comparison across treatment sites
9. Neurocognitive and social functioning in schizophrenia: A 2.5 year follow-up study
10. Social functioning and neurocognitive deficit in outpatients with schizophrenia: A 2-year follow-up
11. The functional consequences of memory impairments of initial work performance in people with schizophrenia
12. Regeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia I: Sensitivity, reliability, and validity
13. The role of cognition in vocational functioning of schizophrenia
14. Nithsdale Schizophrenia Surveys 20: Cognitive functioning in a catchment-area-based population of patients with schizophrenia
15. Psycosocial treatment of schizophrenia
16. Basic elements in biobehavioral treatment and rehabilitation of schizophrenia
17. Research update on the psychosocial treatment of schizophrenia
18. Neurocognitive functioning in patients with schizophrenia: An overview
19. Innovations in skills training for the seriously mentally ill: The UCLA Social and Independent Living Skills Modules
20. New developments in social skills training
21. Normal neurocognitive performance after extended practice in patient with schizophrenia
22. Three-year trials of personal therapy among schizophrenic patients living with or independent of family, II: Effects on adjustment of patients
23. Developmental theory for a cognitive enhancement therapy of schizophrenia
24. Antipsychotic medication effects on neuropsychological functions
25. Cognitive effects of conventional antipsychotics: Another look
26. The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: A review and meta-analysis
27. Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment
28. Neuropsychologic deficit in schizophrenia: Relation to social functioning and effect of antipsychotic drug treatment
29. The effects of clozapine on cognitive functioning in treatment-resistant schizophrenic patients
30. The comparative efficacy and long-term effect of clozapine treatment on neuropsychological test performance
31. The effects of clozapine on symptoms reduction, neurocognitive function, and clinical management in treatment-refractory state hospital schizophrenic inpatients
32. Effects of clozapine on cognitive function in schizophrenia
33. Will the novel antipsychotics significantly ameliorate neuropsychological deficit and improve adaptive functioning in schizophrenia?
34. Risperidone vs haloperidol on reaction time, manual dexterity, and motor learning in treatment-resistant schizophrenia patients
35. Risperidone vs haloperidol on secondary memory: Can newer medications aid learning?
36. The effect of risperidone on cognition in patients with schizophrenia
37. Risperidone, negative symptoms and cognitive deficit in schizophrenia: An open study
38. Attentional improvement following quetiapine fumarate treatment in schizophrenia
39. Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol
40. Cognitive effects of conventional and atypical antipsychotics in schizophrenia
41. Empirical methods for assessing meaningful neuropsychological change following epilepsy surgery